Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

PoreStar Patient Specific Implant

K-Number: K171037 · 2017-12-27

Decision Date2017-12-27
Product CodeJOF
Advisory CommitteeEN
DecisionSubstantially Equivalent

Device Summary

PoreStar Patient Specific Implant is a medical device manufactured by Anatomics Pty, Ltd.. It received FDA 510(k) clearance on 2017-12-27 under approval number K171037. The device is classified under product code JOF. It was reviewed by the EN advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the PoreStar Patient Specific Implant?

PoreStar Patient Specific Implant is a medical device that received FDA 510(k) clearance on 2017-12-27. It is manufactured by Anatomics Pty, Ltd.. The 510(k) number is K171037.

When was PoreStar Patient Specific Implant approved by the FDA?

PoreStar Patient Specific Implant received FDA 510(k) clearance on 2017-12-27, under approval number K171037.

What company makes PoreStar Patient Specific Implant?

PoreStar Patient Specific Implant is manufactured by Anatomics Pty, Ltd..

What is the FDA product code for PoreStar Patient Specific Implant?

The FDA product code for PoreStar Patient Specific Implant is JOF.

Related Clinical Trials

Related PubMed Literature

Other Devices by Anatomics Pty, Ltd.

Related Devices (Code: JOF)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.